A business in context

STIM research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-11 · 0001193125-26-354051 · Items 5.02,9.01

  2. 4 · Ownership change

    Report date 2026-08-13 · 0000921895-26-002204

  3. 8-K · Current report

    Report date 2026-08-11 · 0001193125-26-343474 · Items 2.02,7.01,9.01

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001104659-26-094078

  5. 4 · Ownership change

    Report date 2026-07-23 · 0001982278-26-000006

  6. 8-K · Current report

    Report date 2026-07-09 · 0001193125-26-308921 · Items 5.02,7.01,9.01

  7. 4 · Ownership change

    Report date 2026-07-14 · 0000921895-26-001811

  8. 8-K · Current report

    Report date 2026-06-16 · 0001193125-26-279601 · Items 5.02,9.01

  9. 4 · Ownership change

    Report date 2026-06-15 · 0001193125-26-274343

  10. 4 · Ownership change

    Report date 2026-05-28 · 0001193125-26-274303

  11. 4 · Ownership change

    Report date 2026-05-28 · 0002044406-26-000002

  12. 4 · Ownership change

    Report date 2026-05-28 · 0002004858-26-000002

  13. 4 · Ownership change

    Report date 2026-05-28 · 0001876577-26-000003

  14. 8-K · Current report

    Report date 2026-05-28 · 0001193125-26-248525 · Items 5.07

  15. 8-K · Current report

    Report date 2026-05-18 · 0001193125-26-235481 · Items 5.02,9.01

  16. 8-K · Current report

    Report date 2026-05-05 · 0001193125-26-205117 · Items 2.02,7.01,9.01

  17. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001104659-26-055322

  18. DEF 14A · Proxy statement

    Report date 2026-05-28 · 0001140361-26-013997

  19. 8-K · Current report

    Report date 2026-03-31 · 0001193125-26-143876 · Items 1.01,2.05,5.02,7.01,9.01

  20. 8-K · Current report

    Report date 2026-03-17 · 0001193125-26-109403 · Items 2.02,5.02,7.01,9.01

  21. 10-K · Annual report

    Report date 2025-12-31 · 0001104659-26-029004

  22. 8-K · Current report

    Report date 2026-03-02 · 0001193125-26-085509 · Items 1.01,9.01

  23. 8-K · Current report

    Report date 2026-02-23 · 0001193125-26-071892 · Items 5.02

  24. 8-K · Current report

    Report date 2026-02-10 · 0001193125-26-044912 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2026-01-15 · 0001193125-26-018674 · Items 1.01,9.01

  26. 8-K · Current report

    Report date 2025-12-30 · 0001193125-26-004728 · Items 5.02,9.01

  27. 8-K · Current report

    Report date 2025-11-04 · 0001193125-25-263541 · Items 2.02,5.02,7.01,9.01

  28. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001104659-25-105924

  29. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001558370-25-010180

  30. 8-K · Current report

    Report date 2025-08-05 · 0001193125-25-173033 · Items 1.01,2.02,7.01,9.01

  31. 8-K · Current report

    Report date 2025-07-15 · 0001193125-25-159026 · Items 5.02,7.01,9.01

  32. 8-K · Current report

    Report date 2025-05-22 · 0001193125-25-128678 · Items 5.07

  33. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001558370-25-006384

  34. 8-K · Current report

    Report date 2025-05-06 · 0001193125-25-113283 · Items 2.02,5.02,7.01,9.01

  35. DEF 14A · Proxy statement

    Report date 2025-05-22 · 0001140361-25-013279

  36. 10-K · Annual report

    Report date 2024-12-31 · 0001558370-25-003833

  37. 8-K/A · Current report

    Report date 2025-03-04 · 0001558370-25-003832 · Items 2.02,7.01,9.01

  38. 8-K · Current report

    Report date 2025-03-04 · 0001193125-25-044817 · Items 2.02,7.01,9.01

  39. 8-K · Current report

    Report date 2025-02-24 · 0001193125-25-044451 · Items 5.02

  40. 8-K · Current report

    Report date 2025-02-07 · 0001193125-25-022833 · Items 1.01,8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 4 transaction rows4PSale: 1 transaction rows1SGrant / award: 6 transaction rows6AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 2 transaction rows2G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

22 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-15
2026-06-17
Amin AvinashJ · Other (see filing)
Disposed
Common Stock2934.00.0
2026-06-15
2026-06-17
Amin AvinashJ · Other (see filing)
Disposed
Common Stock34932.00.0
2026-06-15
2026-06-17
Amin AvinashJ · Other (see filing)
Disposed
Common Stock4634.00.0
2026-06-15
2026-06-17
MADRYN HEALTH ADVISORS GP II, LLC; MADRYN HEALTH ADVISORS II, LP; MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP; Madryn Asset Management, LP; Madryn Health Partners II, LP; Madryn Select Opportunities, LPJ · Other (see filing)
Acquired
Common Stock2934.00.0
2026-06-15
2026-06-17
MADRYN HEALTH ADVISORS GP II, LLC; MADRYN HEALTH ADVISORS II, LP; MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP; Madryn Asset Management, LP; Madryn Health Partners II, LP; Madryn Select Opportunities, LPJ · Other (see filing)
Acquired
Common Stock34932.00.0
2026-06-15
2026-06-17
MADRYN HEALTH ADVISORS GP II, LLC; MADRYN HEALTH ADVISORS II, LP; MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP; Madryn Asset Management, LP; Madryn Health Partners II, LP; Madryn Select Opportunities, LPJ · Other (see filing)
Acquired
Common Stock4634.00.0
2026-05-28
2026-05-29
Amin AvinashA · Grant / award
Acquired
Common Stock30000.00.0
2026-05-28
2026-05-29
Cucuz SashaA · Grant / award
Acquired
Common Stock30000.00.0
2026-05-28
2026-05-29
Rosengarten MeganA · Grant / award
Acquired
Common Stock30000.00.0
2026-05-28
2026-05-29
CONLEY SHERYL LA · Grant / award
Acquired
Common Stock30000.00.0
2026-05-28
2026-05-29
CASCELLA ROBERTA · Grant / award
Acquired
Common Stock36250.00.0
2026-05-28
2026-06-17
MADRYN HEALTH ADVISORS GP II, LLC; MADRYN HEALTH ADVISORS II, LP; MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP; Madryn Asset Management, LP; Madryn Health Partners II, LP; Madryn Select Opportunities, LPJ · Other (see filing)
Acquired
Common Stock2071.00.0
2026-05-28
2026-06-17
MADRYN HEALTH ADVISORS GP II, LLC; MADRYN HEALTH ADVISORS II, LP; MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP; Madryn Asset Management, LP; Madryn Health Partners II, LP; Madryn Select Opportunities, LPJ · Other (see filing)
Acquired
Common Stock24658.00.0
2026-05-28
2026-06-17
MADRYN HEALTH ADVISORS GP II, LLC; MADRYN HEALTH ADVISORS II, LP; MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP; Madryn Asset Management, LP; Madryn Health Partners II, LP; Madryn Select Opportunities, LPJ · Other (see filing)
Acquired
Common Stock3271.00.0
2026-05-28
2026-05-29
MUIR GLENN PA · Grant / award
Acquired
Common Stock30000.00.0
2026-05-19
2026-05-20
Chernett JoreyP · Purchase
Acquired
Common Stock100000.01.17
2026-05-12
2026-05-13
Chernett JoreyP · Purchase
Acquired
Common Stock475000.01.34
2026-04-21
2026-04-22
Chernett JoreyP · Purchase
Acquired
Common Stock100000.01.51
2026-04-20
2026-04-22
Chernett JoreyP · Purchase
Acquired
Common Stock100000.01.58
2026-03-19
2026-05-21 · Amendment
Pfanstiel StevenS · Sale
Disposed
Common Stock8569.01.34
2025-07-10
2026-04-01
MADRYN HEALTH ADVISORS GP II, LLC; MADRYN HEALTH ADVISORS II, LP; MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP; Madryn Asset Management, LP; Madryn Health Partners II, LPG · Gift
Acquired
Common Stock337312.00.0
2025-07-10
2026-04-01
MADRYN HEALTH ADVISORS GP II, LLC; MADRYN HEALTH ADVISORS II, LP; MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP; Madryn Asset Management, LP; Madryn Health Partners II, LPG · Gift
Disposed
Common Stock337312.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001227636Neuronetics, Inc.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300T0911ILTTG7P06
GLEIF legal name
Neuronetics, Inc
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2023-08-04T17:19:44Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Neuronetics · alias · wikidata
  • Neuronetics, Inc. · former SEC name · 2009-08-21 to 2026-08-24
  • NEURONETICS INC · former SEC name · 2003-04-15 to 2006-08-16
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$74.89M$79.72M
2023-12-31$71.35M$78.18M
2022-12-31$65.21M$74.39M
2021-12-31$55.31M$68.15M
2020-12-31$49.24M$63.53M
2019-12-31$62.66M$81.83M
2018-12-31$52.78M$70.18M
2017-12-31$40.43M$55.08M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗